The tablet, which will be sold under the brand name 'Paxzen', is being manufactured at Zenara's US FDA and EU approved facility in Hyderabad.
Pfizer has said that Paxlovid reduces the risk of hospitalisation or death in Covid-19 patients by 89 per cent.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.